Pluri (PLUR) Shares Outstanding (2010 - 2025)
Pluri (PLUR) posted quarterly Shares Outstanding (Entity) of $10.0 million for Q4 2025, up 79.28% year-over-year from $5.6 million in Q4 2024, and up 22.24% quarter-over-quarter from $8.2 million in Q3 2025.
Pluri (PLUR) Shares Outstanding (2010 - 2025) Analysis & Trends
Pluri (PLUR) has reported Shares Outstanding (Entity) for 16 consecutive years, with $10.0 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Shares Outstanding (Entity) rose 79.28% year-over-year to $10.0 million; the TTM figure through Dec 2025 stood at $10.0 million (up 79.28% YoY), while the FY2025 annual figure was $6.3 million, up 17.17% from the prior year.
- Shares Outstanding (Entity) rose to $10.0 million in Q4 2025 per PLUR's latest filing, from $8.2 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $10.0 million in Q4 2025 and bottomed at $4.0 million in Q1 2021.
- Historically, Shares Outstanding (Entity) has averaged $5.4 million across 5 years, with a median of $5.2 million in 2023.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) rose 1.68% — and 2025, when it surged 79.28%.
- Pluri's Shares Outstanding (Entity) stood at $4.0 million in 2021, then advanced by 18.82% to $4.8 million in 2022, then advanced by 8.85% to $5.2 million in 2023, then gained by 6.82% to $5.6 million in 2024, then surged by 79.28% to $10.0 million in 2025.
- Business Quant data shows PLUR's Shares Outstanding (Entity) at $10.0 million in Q4 2025, $8.2 million in Q3 2025, and $6.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | Pluri | 16.21 Mn | 3.72 Mn | 86,000.00 | 9.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.26 Mn |
| Sep 30, 2025 | 9.00 Mn |
| Jun 30, 2025 | 6.34 Mn |
| Mar 31, 2025 | 6.56 Mn |
| Dec 31, 2024 | 5.55 Mn |
| Sep 30, 2024 | 5.46 Mn |
| Jun 30, 2024 | 5.24 Mn |
| Mar 31, 2024 | 5.22 Mn |
| Dec 31, 2023 | 5.19 Mn |
| Sep 30, 2023 | 5.17 Mn |
| Jun 30, 2023 | 4.58 Mn |
| Mar 31, 2023 | 4.99 Mn |
| Dec 31, 2022 | 4.15 Mn |
| Sep 30, 2022 | 4.07 Mn |
| Jun 30, 2022 | 4.02 Mn |
| Mar 31, 2022 | 4.03 Mn |
| Dec 31, 2021 | 4.02 Mn |
| Sep 30, 2021 | 4.00 Mn |
| Jun 30, 2021 | 3.51 Mn |
| Mar 31, 2021 | 3.70 Mn |